| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
*







From Brigham and Women's Hospital*
and Harvard
Medical School, Boston, Massachusetts; University of
Leuven,
Leuven, Belgium; University
Hospital,
Lund, Sweden; Memorial
Sloan-Kettering Cancer Center,§
New York, New
York; Yale University School of Medicine,¶
New
Haven, Connecticut, and the University of Cagliari,||
Sardinia, Italy
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
As a reflection of the potential importance of the clinical application of cytogenetics to soft-tissue tumors, an international collaborative group (the CHAMP study group) comprising cytogeneticists, pathologists, and surgeons was established in 1993 (and first met in 1994) to correlate chromosomal analysis and morphology in these lesions. Although the relevance of karyotypic analysis has now been well established in small-round-cell neoplasms and in lipomatous tumors,1,2,5, it has been the group's goal to study as large a spectrum as possible of connective tissue neoplasia, subject to the availability of an adequate number of karyotyped specimens. Work done in 1996 on the family of pleomorphic (malignant fibrous histiocytoma (MFH)-like) sarcomas revealed little in the way of meaningful diagnostic or prognostic correlations, mainly due to the extreme complexity of the karyotypes in these lesions.6 It was then decided to move on to analyze the group of spindle-cell sarcomas arising in soft tissue, and it is these lesions that are the focus of the present report.
| Materials and Methods |
|---|
|
|
|---|
For cytogenetic analysis, fresh tumor specimens in all cases were disaggregated with collagenase, cultured (for less than 10 days), harvested, and stained as previously described.7 Chromosomal aberrations and karyotypes were described according to the International System for Human Cytogenetic Nomenclature.8 In light of the complexity of many of the karyotypes and after initial appraisal of the results (as well as data in the literature), the chromosome aberrations identified were broken down into the following subgroups: t(X;18)(p11;q11), rearrangements of 12q (distinguishing as an important subset those with 12q1315 aberrations), ring chromosomes, homogeneously staining regions/double minute chromosomes (hsr/dmin), trisomy 7, deletion or rearrangement of the following: 1p, 4q, 6q, 9p, 10p, 11p, 11q, 12p, 17p, 22q, Xp, Xq, aberrations other than those listed above (other), and normal karyotype (N).
For histopathological analysis, all of the paraffin blocks in each of the 136 cases were recut and re-examined by three of the group members (C.D.M. Fletcher, J. Rosai, and G. Tallini) without any knowledge of the clinical or karyotypic data or of the previous (original) diagnosis. Immunohistochemical analysis, using conventional markers of differentiation routinely used in the diagnosis of soft-tissue neoplasms, was performed in almost all of the cases. When available, electron microscopic materials were reappraised at the time of group review. The tumors were then classified according to the following morphological criteria.
Leiomyosarcoma was characterized by the presence of eosinophilic spindle cells with blunt-ended, cigar-shaped nuclei arranged mainly in a fascicular pattern, with fascicles often intersecting at 90° angles. More pleomorphic examples of this tumor type had been included in a previous CHAMP study and were not reanalyzed here. Immunohistochemically, tumors with these morphological features were required to show extensive positivity for smooth muscle actin (SMA); desmin was also strongly, if only focally, positive in most cases.
Malignant peripheral nerve sheath tumor (MPNST) was characterized usually by the presence of pale spindle cells with indistinct cytoplasmic margins and wavy, tapering, or S-shaped nuclei, often arranged in fascicles with alternating cellular and more myxoid areas and with a frequent tendency to show perivascular accentuation. Tumors with these suggestive features were also required to show either S-100 protein immunopositivity (in the absence of epithelial membrane antigen or keratin reactivity), clear evidence of origin from a nerve or neurofibroma, or ultrastructural evidence of Schwann cell differentiation or else to occur in a patient with well documented neurofibromatosis type I (von Recklinghausen's disease).
Synovial sarcoma was subclassified into three groups: monophasic (spindle cell), biphasic, and poorly differentiated. Biphasic lesions were characterized by the classical admixture of basophilic spindle cell fascicles and glandular or epithelial-lined structures; monophasic lesions, in addition to a basophilic fascicular appearance, commonly showed wiry stromal collagen and focal hyalinization. All three subtypes were often associated with a pericytoma-like branching vascular pattern, focal calcification, and stromal mast cells. Immunohistochemically, all cases were required to show convincing positivity for epithelial membrane antigen and/or keratin in the spindle or poorly differentiated cells, aside from any positivity in glandular structures. Staining for desmin was by definition absent, and any positivity for actin should only be focal.
Solitary fibrous tumor was characterized by fairly uniform pale spindle cell morphology with ovoid or tapering, often vesicular nuclei, a patternless (or very focally fascicular) architecture, marked variation in cellularity with frequent areas of stromal hyalinization, the common presence of a branching pericytoma-like vasculature, and immunopositivity for CD34 in the absence of reactivity for epithelial membrane antigen, keratin, S-100 protein, and desmin.
Miscellaneous
This category included examples of 1) myofibroblastic sarcoma, being spindle-cell sarcomas reminiscent of leiomyosarcoma except for their paler cytoplasm and more pointed or tapering nuclei, 2) mesenchymal chondrosarcoma, bearing a close resemblance to so-called hemangiopericytoma except for the presence of cartilaginous nodules, 3) inflammatory myofibroblastic tumor/inflammatory fibrosarcoma, being composed of fibroblastic/myofibroblastic fascicles with minimal to mild nuclear atypia and a prominent lymphoplasmacytic infiltrate in the stroma, 4) hemangiopericytoma, being tumors composed of close-packed uniform short spindle cells associated with numerous thin-walled, variably dilated branching vessels and without any immunohistochemical evidence of specific differentiation, 5) infantile fibrosarcoma, being a fascicular spindle-cell sarcoma with a herringbone architecture, palely eosinophilic cytoplasm, tapering nuclei, and no immunohistochemical evidence of specific differentiation, and 6) unclassified spindle-cell sarcomas, being lesions that lacked either distinctive architectural or immunophenotypic features.
| Results |
|---|
|
|
|---|
|
|
Forty-one cases were classified histologically as leiomyosarcoma. Patient age ranged from 2 to 86 years; 31 patients were aged 50 or more. Twenty-one patients were male and twenty were female. Anatomical distribution was as follows: limbs and limb girdles, 24 cases; trunk, 4 cases; abdomen/retroperitoneum, 9 cases; and other, 4 cases. Among the limb and truncal lesions, 7 were subcutaneous and 17 were subfascial. Thirty-two cases were high grade, 8 were intermediate, and 1 was low grade.
Twenty-four cases (58.5%) had a normal karyotype, most likely representing overgrowth of non-neoplastic stromal cells in tissue culture. One case showed loss of the Y chromosome as a sole anomaly. Sixteen cases (39%) showed complex karyotypes with multiple clonal abnormalities, among which the most frequent were loss or rearrangement of 12q (nine cases, three involving 12q1315), loss of 1p (eight cases), loss of 11q or 10p (six cases each), and loss of 6q, 11p, or 22q (four cases each). Three cases each showed either deletion or rearrangement of 17p or a ring chromosome. All sixteen cases showed a variety of other less frequent aberrations affecting multiple different chromosomes. There were no recognizable differences in terms of anatomical location, depth, grade, development of metastases, or tumor-related death between tumors having a normal or abnormal karyotype, nor did any of the clonal aberrations detected show any evident association with any of these clinical parameters.
Malignant Peripheral Nerve Sheath Tumor
Twenty-seven cases were classified histologically as MPNST. Patient age ranged from 10 to 74 years, and the age distribution was evenly spread. Sixteen patients were male and ten were female; seven patients had von Recklinghausen's disease. Anatomical distribution was as follows: limbs and limb girdles, 16 cases; trunk, 4 cases; retroperitoneum, 4 cases; and other, 3 cases. Among the limb and truncal lesions, one tumor was subcutaneous and the other 18 were subfascial. Sixteen cases were high grade, nine were intermediate, and two were low grade. Two tumors arose in a pre-existing neurofibroma, and three tumors showed evidence of heterologous differentiation.
Seven cases (26%) had a normal karyotype. Twenty cases (74%) showed clonal aberrations, most often with a complex karyotype. The most frequent abnormalities were loss or rearrangement of 10p, 11q, or 17q (nine cases each) and loss or rearrangement of 1p, 9p, 17p, or 22q (eight cases each). Seven cases each showed a ring chromosome, trisomy 7, or rearrangement of 11p. Only two cases showed rearrangement of 12q1315. Eighteen cases showed a variety of other less frequent aberrations affecting multiple different chromosomes. Complex rearrangements were more common in patients with von Recklinghausen's disease or in tumors showing heterologous differentiation. Among the cases with 17q rearrangements, three of nine had von Recklinghausen's disease. There were no evident correlations between karyotypic abnormality and any clinical parameter in these patients.
Synovial Sarcoma
Forty-two cases were classified histologically as synovial sarcoma. Patient age ranged from 11 to 82 years; 31 patients were aged 50 or under. The sex incidence was equal. Anatomical distribution was as follows: lower limb and limb girdle, 23 cases; upper limb and limb girdle, 7 cases; trunk, 4 cases; and other, 7 cases. In one case the location was unknown. Among the limb and truncal lesions, 2 cases were subcutaneous and 32 were subfascial. Twenty-nine cases were monophasic (spindle cell), eight were poorly differentiated, and five were biphasic. Twenty-seven tumors were high grade and fifteen were intermediate grade.
Eleven tumors (26%) had a normal karyotype. Thirty-one cases (74%) showed clonal abnormalities, most of which were relatively simple. Twenty-six cases (84% of those with an abnormal karyotype) showed a t(X;18)(p11;q11); in twenty-two of these, this translocation was combined with a variety of other infrequent clonal aberrations, among which were rearrangements of 11q (seven cases), 22q (five cases), and 11p (four cases). Three cases each showed rearrangements of 12q, 17p, or Xp or a ring chromosome. Four cases showed clonal abnormalities in the absence of either a classical t(X;18) or complex variant translocations involving chromosomes X and 18. One case showed a simple Xq rearrangement, two showed multiple chromosome rearrangements (one being very complex), and one showed multiple trisomies. There was no evident correlation between karyotype and either histological subtype or any recorded clinical parameter. In particular, there were no clinicopathological differences between those cases having or not having an X;18 translocation.
Solitary Fibrous Tumor
Nine cases were classified histologically as solitary fibrous tumor. Patient age ranged from 46 to 85 years (median, 53); there were six males and three females. Anatomical distribution was as follows: limbs and limb girdles, 5 cases; abdomen/retroperitoneum, 2 cases; and 1 case each in the pleura and oral cavity. Among the limb and limb girdle lesions, one was subcutaneous and the other four were subfascial. Unusually (and most likely reflecting the sarcoma interest of the institutions concerned), six of the nine cases showed histological features (mitoses > 4 per 10 high-power fields, necrosis) of malignancy.9
Two cases had a normal karyotype and seven showed clonal aberrations.
The cytogenetic abnormalities identified were different in every case,
and the results are detailed in Table 3
.
The only possible similarities detected were involvement of the
pericentromeric region of chromosome 17 in two cases and gain of
chromosomes 21 in two other cases. There were no evident correlations
between karyotype and histology, anatomical location, or clinical
outcome. In fact, the tumor with the most complex karyotype (ref Lu
265) appeared histologically benign and has shown no evidence of
recurrence at 6 years follow-up.
|
Eleven cases fell outside the four categories detailed above, and
the karyotypes are detailed in Table 4
.
Three were classified histologically as myofibroblastic sarcoma, of
which two were examples of the recently described low-grade
type10
and one was high grade. All three arose in adults
(two females and one male); two were located on the trunk and one on
the neck. One showed a normal karyotype, the high-grade lesion (ref Lu
287) showed an exceedingly complex karyotype, including rearrangements
of 1p, 9p, and 10p, and the remaining low-grade lesion (ref Lu 165)
showed unbalanced aberrations, including changes in Xp and 11q. Both
cases had similar deletions of 15q. There was one case of meningeal
hemangiopericytoma with lung metastasis, which showed trisomy 5 as the
sole clonal rearrangement. There was one extraskeletal mesenchymal
chondrosarcoma of the lower limb in an adult female, which showed
rearrangements of 12q1315 and 4q as well as a variety of other
rearrangements. There was one inflammatory myofibroblastic tumor in the
abdomen of a 5-year-old boy, the karyotype of which was normal. There
was one infantile fibrosarcoma in the leg of a 5-month-old girl, which
showed characteristic gain of chromosomes 11, 17, and 20. There was one
case in which the study group pathologists could not decide between
leiomyosarcoma and myofibroblastic sarcoma (myosarcoma NOS), occurring
in the chest wall of a 67-year-old female, which showed a complex
karyotype with numerous rearrangements. There were three unclassified
sarcomas, two of which showed a normal karyotype and one of which had a
complex karyotype with multiple aberrations. Unfortunately, no
ultrastructural data were available for these latter three cases.
|
| Discussion |
|---|
|
|
|---|
With the notable exception of synovial sarcoma, in which more than 90% of the published cases have shown an X;18 translocation with or without additional aberrations,11,12 other types of spindle-cell sarcoma have generally not been associated with any consistent or specific cytogenetic aberration. Because of this, interest instead has been focused on the frequency with which chromosomal regions harboring potentially relevant tumor suppressor genes (especially TP53 on 17p and NF1 on 17q) are involved in these tumor types.
Using data from the latest Catalog of Chromosome Aberrations in Cancer,13 among the 51 leiomyosarcomas with previously published karyotypes (of which less than half were located in soft tissue rather than visceral locations), the most frequent rearrangements in soft-tissue examples (almost always in the setting of a complex karyotype) involved bands 1p36, 14p11, 19q13, 20q13, and 22q13. In addition, trisomy 7 and losses (monosomy) of chromosomes 4, 13, 14, 18, and 22 seem common. Our own data certainly support a central role for deletion of the chromosome arm 1p in these lesions,14,15 although given the usual complexity of the karyotypes in this tumor type, it is impossible to determine whether a given aberration is a primary nonrandom event or else a secondary (or unrelated) event of unknown (or dubious) significance, at least in terms of tumor specificity. The involvement of 12q in nine cases (of which three showed 12q1315 rearrangements) suggests at least some pathogenetic similarity with uterine benign smooth muscle tumors in which up to 50% have 12q1315 rearrangements.16,17 In future studies, it would be of interest to compare the karyotype of those gastrointestinal stromal tumors that show smooth muscle differentiation with that of leiomyosarcomas at other sites.
As with leiomyosarcomas, the karyotypes of the less than 50 published examples of MPNST have generally been both very variable and complex.18-20 The most frequently rearranged chromosome bands have been 7p22, 17p11 (the location of the TP53 gene), 17q11 (the location of the NF1 gene), and 22q11 (the location of the NF2 gene). Among the numerical aberrations identified, commonest have been trisomy 7 and losses of X, 10, 16, 17, 18, 19, and 22. Our own data have served to further implicate chromosome regions 17q, 17p, 10p, and 22q and have drawn attention to a potential role for 1p and 11q. In fact, the relative frequency of 1p rearrangement in both leiomyosarcomas and MPNSTs adds weight to the hypothetical presence of one or more tumor-suppressor genes or else an (activated) proto-oncogene in that location. Our data further confirm the relatively frequent involvement of 17q and 22q (and hence the possible involvement of the NF1 or NF2 genes) in sporadic cases of MPNST unassociated with neurofibromatosis.
As far as synovial sarcomas are concerned, we were not able to add much to the existing literature as there are almost 100 previously published cases with abnormal karyotypes of which 84% have shown a t(X;18)(p11;q11) in 21% as the sole anomaly.13 We too found that most of our cases showed additional aberrations (albeit much less complex than those in leiomyosarcoma or MPNST) but without significant predilection for any particular chromosomal region. Previous data13,21 (which included six tumors from the present series21 ) have suggested gains of chromosomes 7, 8, and 12 and structural rearrangements of 3p21, 5q11, 19q13, and 22p11 as the commonest secondary aberrations, but our series may be too small to validate this. Among the four cases in our series with aberrations other than t(X;18), one showed involvement of Xp in alternative rearrangements. Our data confirmed previous evidence that there were no discernible differences (at the chromosomal level) between the three morphological subsets of synovial sarcoma. However, it is our intention now to further study the entire series (including those with a seemingly normal karyotype) using reverse transcription polymerase chain reaction to determine what proportion of the cases as a whole had molecular evidence of a t(X;18) and, at the same time, to see whether recently presented data concerning the correlations between the chromosomal breakpoint or fusion gene (ie, SYT-SSX1 or SYT-SSX2) with both morphology and clinical outcome3 can be reproduced.
Concerning solitary fibrous tumor, there are few published data regarding its karyotype,22 the principal reason for which is likely reflected in the fact that this diagnosis has gained popularity (at extrapleural locations) only in the past few years. Before that time, most such cases were subsumed principally in the category of hemangiopericytoma, an entity that is hard to define and that is regarded by some as a pattern shared by a very heterogeneous and broad group of neoplasms. Published cytogenetic data concerning hemangiopericytoma includes less than 20 cases,13 but among these, the most frequent rearrangements have involved 12q1315 (50% of cases) and 3p1221 (37% of cases). In the present study, seven tumors had originally been classified (before the study review) as hemangiopericytoma, and two of these had been published previously.23 Among these seven, five were reclassified as examples of solitary fibrous tumor, one was reclassified as inflammatory myofibroblastic tumor, and one was reclassified as a cellular benign fibrous histiocytoma (and excluded from this analysis).
Among the nine cases diagnosed as solitary fibrous tumor in the present study, there were no consistent cytogenetic abnormalities, although it was notable that the karyotypes were all relatively simple when compared with those of leiomyosarcoma or MPNST. Only one case (from the leg of an adult male) showed a 12q rearrangement. Whether this failure to find any reproducible or distinctive chromosomal aberration in these lesions reflects reality or whether it might be due either to the fact that six of nine lesions (unusually) were histologically malignant or that the morphological pattern that we recognize as solitary fibrous tumor is a shared or nonspecific appearance can only be a matter of speculation at this time. Having said that, there is no logical basis on which to believe that malignancy would have diminished karyotypic consistency (especially in the setting of relatively simple karyotypes), and furthermore, we believe that the morphological criteria applied by the study pathologists when making this diagnosis were as strict as can reasonably be expected. Clearly, more karyotypic data on this tumor type need to be accumulated before any more concrete interpretation is possible.
From the cases in the miscellaneous category it is difficult to draw any significant conclusions. The one case of infantile fibrosarcoma showed the trisomies known to be customary in this tumor type.24,25 No cases of adult fibrosarcoma were available for study, largely because this diagnosis is scarcely used nowadays (except for special morphological subsets, such as inflammatory fibrosarcoma and sclerosing epithelioid fibrosarcoma). The previously published karyotypic data on just six adult fibrosarcomas have revealed complexity with no reproducible abnormalities,13,26,27 and the one case reported with an X;18 translocation28 is now generally accepted to have been a monophasic synovial sarcoma. Among the other cases studied, the aberrations that we identified in one case each of meningeal hemangiopericytoma and mesenchymal chondrosarcoma showed no clear relationship to previously reported findings in these tumor types.
In conclusion, this karyotypic study of a large series of spindle-cell sarcomas, although confirming the reproducibility of the X;18 translocation in synovial sarcoma, has provided further substantial evidence that most other sarcomas of monomorphic spindle-cell type do not show tumor-specific chromosomal abnormalities comparable to the type seen in round-cell sarcomas, lipomatous tumors, and some myxoid neoplasms. Rather, they usually have complex karyotypes with multiple aberrations, and overall, this complexity does not correlate consistently with pathological or clinical parameters, such as histological grade or prognosis. The cytogenetic complexity of these lesions essentially parallels that of their morphologically pleomorphic counterparts (the MFH-like group of tumors6 ); thus, the temptation to attribute the chromosomal anarchy seen in pleomorphic sarcomas to their relative lack of differentiation or their gross aneuploidy cannot be so easily sustained. Instead, it seems more likely that this subset of mesenchymal neoplasms has a different oncogenetic basis (or generic mechanism) that, rather than being predicated on a single (or primary and defining) genetic event, perhaps results from the progressive accumulation of multiple genetic hits in the manner now believed to operate for most epithelial malignancies. However, even that parallel will be limited by the fact that dysplastic or preinvasive precursors are not known to exist among these mesenchymal neoplasms, and hence, hypotheses regarding the acquisition of mutations that correlate with tumor development will be more difficult to substantiate. Although the role of known tumor suppressor genes (such as TP53, NF1, and NF2) is well documented and recognized in many of these tumor types, the increasingly consistent evidence that an additional such gene is likely located on 1p29,30 merits further investigation, especially as this chromosome arm seems to be rearranged in a wide variety of tumor types.
| Acknowledgements |
|---|
| Footnotes |
|---|
Supported by the Swedish Cancer Society, the Belgian Interuniversity Poles of Attraction Program (initiated by the Belgian State, Prime Minister's office, Science Policy Programming), and the Rockefeller Foundation.
Accepted for publication February 25, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
E. Engel, M. Butler, and J. Anain Jr Leiomyosarcoma of the Foot: A Case Study J Am Podiatr Med Assoc, November 1, 2007; 97(6): 475 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Montgomery, P. Argani, J. L. Hicks, A. M. DeMarzo, and A. K. Meeker Telomere Lengths of Translocation-Associated and Nontranslocation-Associated Sarcomas Differ Dramatically Am. J. Pathol., May 1, 2004; 164(5): 1523 - 1529. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Linn, R. B. West, J. R. Pollack, S. Zhu, T. Hernandez-Boussard, T. O. Nielsen, B. P. Rubin, R. Patel, J. R. Goldblum, D. Siegmund, et al. Gene Expression Patterns and Gene Copy Number Changes in Dermatofibrosarcoma Protuberans Am. J. Pathol., December 1, 2003; 163(6): 2383 - 2395. [Abstract] [Full Text] |
||||
![]() |
F. Perrone, S. Tabano, F. Colombo, G. Dagrada, S. Birindelli, A. Gronchi, M. Colecchia, M. A. Pierotti, and S. Pilotti p15INK4b, p14ARF, and p16INK4a Inactivation in Sporadic and Neurofibromatosis Type 1-related Malignant Peripheral Nerve Sheath Tumors Clin. Cancer Res., September 15, 2003; 9(11): 4132 - 4138. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mertens, U. Stromberg, N. Mandahl, P. D. Cin, I. De Wever, C. D. M. Fletcher, F. Mitelman, J. Rosai, A. Rydholm, R. Sciot, et al. Prognostically Important Chromosomal Aberrations in Soft Tissue Sarcomas: A Report of the Chromosomes and Morphology (CHAMP) Study Group Cancer Res., July 15, 2002; 62(14): 3980 - 3984. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Bijwaard, J. F. Fetsch, R. Przygodzki, J. K. Taubenberger, and J. H. Lichy Detection of SYT-SSX Fusion Transcripts in Archival Synovial Sarcomas by Real-Time Reverse Transcriptase-Polymerase Chain Reaction J. Mol. Diagn., February 1, 2002; 4(1): 59 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Einhorn and G. P. Nielsen Case 1-2001- A 26-Year-Old Man with a Mass in the Knee N. Engl. J. Med., January 11, 2001; 344(2): 124 - 131. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |